Hospital Variation in Cancer Treatments and Survival OutComes of Advanced Melanoma Patients: Nationwide Quality Assurance in The Netherlands

J. van Breeschoten, A.J.M. van den Eertwegh, L.C. de Wreede, D.L. Hilarius, E.W. van Zwet, J.B. Haanen, C.U. Blank, M.J.B. Aarts, F.W.P.J. van den Berkmortel, J.W.B. de Groot, G.A.P. Hospers, E. Kapiteijn, D. Piersma, R.S. van Rijn, M.A.M. Stevense-den Boer, A.A.M. van der Veldt, G. Vreugdenhil, M.J. Boers-Sonderen, K.P.M. Suijkerbuijk, M.W.J.M. Wouters*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number5077
Number of pages12
JournalCancers
Volume13
Issue number20
DOIs
Publication statusPublished - 1 Oct 2021

Keywords

  • advanced melanoma
  • survival
  • center variation
  • METASTATIC MELANOMA
  • POOLED ANALYSIS
  • DABRAFENIB
  • MULTICENTER
  • VEMURAFENIB
  • IMPACT

Cite this